Home/ Stocks/ ARWR

Arrowhead Research Corporation

ARWR XNAS

$72.69 -5.25 (-6.74%) ▼ 15-min delayed

Open

$76.50

High

$77.92

Low

$72.61

Volume

2.70M

Market Cap

$10.24B

About Arrowhead Research Corporation

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 711 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$73.74M	$-137,572,000	$-0.93
Q1 2026	$264.03M	$28.24M	$0.22
FY 2025	$829.45M	$30.11M	$-0.01
Q3 2025	$27.77M	$-178,652,000	$-1.26

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for ARWR yet. Check out our latest market news or earnings calendar.

Get ARWR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Arrowhead Research Corporation.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.